{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:46:31Z","timestamp":1772088391005,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,25]]},"DOI":"10.7759\/cureus.104264","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:50:43Z","timestamp":1772085043000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug Prescribing Patterns in Geriatric Patients With Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Deeksha","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sartaj","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K K","family":"Sawlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Katiayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kauser","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Pradeepa R","year":"2021","unstructured":"Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021, 69:2932-8. 10.4103\/ijo.IJO_1627_21","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1801","article-title":"Diabetes in older adults","volume":"35","author":"Kirkman MS","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, et al.. Diabetes in older adults. Diabetes Care. 2012, 35:2650-64. 10.2337\/dc12-1801","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14283\/jfa.2017.39","article-title":"An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017","volume":"7","author":"Sinclair AJ","year":"2018","unstructured":"Sinclair AJ, Abdelhafiz A, Dunning T, et al.. An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J Frailty Aging. 2018, 7:10-20. 10.14283\/jfa.2017.39","journal-title":"J Frailty Aging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_81_17","article-title":"Polypharmacy and comorbidity status in the treatment of type 2 diabetic patients attending a tertiary care hospital: an observational and questionnaire-based study","volume":"9","author":"Indu R","year":"2018","unstructured":"Indu R, Adhikari A, Maisnam I, Basak P, Sur TK, Das AK. Polypharmacy and comorbidity status in the treatment of type 2 diabetic patients attending a tertiary care hospital: an observational and questionnaire-based study. Perspect Clin Res. 2018, 9:139-44. 10.4103\/picr.PICR_81_17","journal-title":"Perspect Clin Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher RL","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014, 13:57-65. 10.1517\/14740338.2013.827660","journal-title":"Expert Opin Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1546841","article-title":"An update on the clinical consequences of polypharmacy in older adults: a narrative review","volume":"17","author":"Wastesson JW","year":"2018","unstructured":"Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018, 17:1185-96. 10.1080\/14740338.2018.1546841","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni AA","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004, 57:6-14. 10.1046\/j.1365-2125.2003.02007.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref8","article-title":"How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators","author":"World Health Organization","year":"1993","unstructured":"World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. World Health Organization, Geneva, Switzerland; 1993."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.179352","article-title":"A closer look at the World Health Organization's prescribing indicators","volume":"7","author":"Ofori-Asenso R","year":"2016","unstructured":"Ofori-Asenso R. A closer look at the World Health Organization's prescribing indicators. J Pharmacol Pharmacother. 2016, 7:51-4. 10.4103\/0976-500X.179352","journal-title":"J Pharmacol Pharmacother"},{"key":"ref10","unstructured":"International Diabetes Federation. The Diabetes Atlas. (2021). Accessed. February 11, 2026: https:\/\/diabetesatlas.org."},{"key":"ref11","unstructured":"World Health Organization. WHO Model List of Essential Medicines - 23rd list, 2023. (2023). Accessed. February 11, 2026: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott SD","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, et al.. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019, 380:347-57. 10.1056\/NEJMoa1812389","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"Pattern of management of febrile neutropenia among breast cancer patients treated with different chemotherapeutic regimens","volume":"7","author":"Singh A","year":"2018","unstructured":"Singh A, Mohamedali SP, Ansari M. Pattern of management of febrile neutropenia among breast cancer patients treated with different chemotherapeutic regimens. Int J Basic Clin Pharmacol. 2018, 7:1829-36.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3673","article-title":"Gender differentials in the choice of in-patient healthcare services among the older adults in India: a cross-sectional study","volume":"38","author":"Hasan MS","year":"2023","unstructured":"Hasan MS, Ghosal S. Gender differentials in the choice of in-patient healthcare services among the older adults in India: a cross-sectional study. Int J Health Plann Manage. 2023, 38:1464-82. 10.1002\/hpm.3673","journal-title":"Int J Health Plann Manage"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29068","article-title":"Effects of polypharmacy in elderly diabetic patients: a review","volume":"14","author":"Kumari S","year":"2022","unstructured":"Kumari S, Jain S, Kumar S. Effects of polypharmacy in elderly diabetic patients: a review. Cureus. 2022, 14:e29068. 10.7759\/cureus.29068","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/20420986211072383","article-title":"Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Doni K","year":"2022","unstructured":"Doni K, B\u00fchn S, Weise A, et al.. Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Drug Saf. 2022, 13:3. 10.1177\/20420986211072383","journal-title":"Ther Adv Drug Saf"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1940_17","article-title":"Prescribing generics: all in a name","volume":"147","author":"Roy V","year":"2018","unstructured":"Roy V, Rana P. Prescribing generics: all in a name. Indian J Med Res. 2018, 147:442-4. 10.4103\/ijmr.IJMR_1940_17","journal-title":"Indian J Med Res"},{"key":"ref18","unstructured":"World Health Organization. Medicines. (2026). Accessed. February 11, 2026: https:\/\/www.who.int\/health-topics\/medicines."},{"key":"ref19","unstructured":"Government of India, Ministry of Health and Family Welfare. National List of Essential Medicines (NLEM). (2022). Accessed. February 11, 2026: https:\/\/www.mohfw.gov.in\/."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00706-4","article-title":"Suitable use of injectable agents to overcome hypoglycemia risk, barriers, and clinical inertia in community-dwelling older adults with type 2 diabetes mellitus","volume":"36","author":"Valencia WM","year":"2019","unstructured":"Valencia WM, Florez HJ, Palacio AM. Suitable use of injectable agents to overcome hypoglycemia risk, barriers, and clinical inertia in community-dwelling older adults with type 2 diabetes mellitus. Drugs Aging. 2019, 36:1083-96. 10.1007\/s40266-019-00706-4","journal-title":"Drugs Aging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467813-drug-prescribing-patterns-in-geriatric-patients-with-type-2-diabetes-mellitus-at-a-tertiary-care-teaching-hospital-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:50:44Z","timestamp":1772085044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467813-drug-prescribing-patterns-in-geriatric-patients-with-type-2-diabetes-mellitus-at-a-tertiary-care-teaching-hospital-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.104264","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}